GLP-1 Support
US$ 23.44
glp 1 history Another milestone in the evolution of GLP-1-based diabetes therapies american diabetes association pancreatitis history
Description
Adjacent indications such as sarcopenia, metabolic syndrome, and MAFLD represent significant growth opportunities, provided they are thoughtfully integrated into the overall portfolio strategy
[DOI] [PMC free article] [PubMed] [Google Scholar] 113.Alkhouri N, Herring R, Kabler H, Kayali Z, Hassanein T, Kohli A, et al
The goal is to identify individuals for whom GLP-1 therapy is clinically appropriate and likely to support sustainable outcomes when administered under supervision
PubMed: 2024, February 26
Int J Exp Diabetes Res 2001
6:821-832 [PubMed: 29501322] 22
